Patent Assignment
Reel/Frame 050072/0425
Assignment of Assignor's Interest
Recorded: 2019-08-16
Pages: 5
Assignor
TARSA THERAPEUTICS, INC.
Executed: 2018-11-20
Assignee
TAURUS DEVELOPMENT COMPANY LLC
505 COAST BLVD. SO., SUITE 102, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Room Temperature Stable Oral Calcitonin Formulation
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 16, 2019
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 050072/0341 →
Assignment of Assignor's Interest
Aug 16, 2019
From: GILLIGAN, JAMES P.; MAURER, GEORGE R.; RAILKAR, ANIRUDDHA M.; BAUER, PHIL
To: TARSA THERAPEUTICS, INC.
Reel/Frame 050072/0389 →
Security Interest
Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Assignment of Assignor's Interest
Jan 5, 2023
From: TAURUS DEVELOPMENT COMPANY LLC
To: PARK THERAPEUTICS, INC.
Reel/Frame 062287/0841 →
Release of Security Interest
Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →
Corrective Assignment to Correct the the Assignment Previously Recorded Previously Recorded at Reel: 068713 Frame: 0499. Assignor(S) Hereby Confirms the Assignment.
Oct 24, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 070760/0864 →